ClinicalTrials.Veeva

Menu
W

Worldwide Clinical Trials | San Antonio

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Relugolix
OC-01
Estradiol
Emricasan
TNX-102
Sabirnetug
Sabirnetug IV
varenicline
steroid
Norethindrone Acetate

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 20 total trials

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for...

Enrolling
Uterine Fibroids
Endometriosis
Drug: Relugolix Combination Tablet

A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants

Enrolling
Alzheimer Disease
Drug: sabirnetug (ACU193)
Combination Product: Sabirnetug + rHuPH20

The purpose of this study is to assess the contraceptive efficacy of relugolix combination therapy.

Active, not recruiting
Contraception
Drug: Relugolix Combination Therapy

Trial sponsors

M
F
Sumitomo Pharma logo
T
Tonix Pharmaceuticals logo
A
Alcon logo
H
Oyster Point Pharma logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems